Fertility Medicines Approved in the EU (EMA)

Medicines the European Medicines Agency has recommended for use in the European Union on this topic.

Each number has its full source under its own list below.

Medicines authorised in the EU

10 medicines (authorised now). Newest first. Each links to its EMA page.

At the source
  • Ganirelix Gedeon Richter

    Active substance: ganirelix acetate

    EMEA/H/C/005641
  • Rekovelle

    Active substance: follitropin delta

    EMEA/H/C/003994
  • Bemfola

    Active substance: follitropin alfa

    EMEA/H/C/002615
  • Ovaleap

    Active substance: follitropin alfa

    EMEA/H/C/002608
  • Pergoveris

    Active substance: follitropin alfa;lutropin alfa

    EMEA/H/C/000714
  • Ovitrelle

    Active substance: choriogonadotropin alfa

    EMEA/H/C/000320
  • Luveris

    Active substance: lutropin alfa

    EMEA/H/C/000292
  • Orgalutran

    Active substance: ganirelix

    EMEA/H/C/000274
  • Puregon

    Active substance: follitropin beta

    EMEA/H/C/000086
  • GONAL-f

    Active substance: follitropin alfa

    EMEA/H/C/000071

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

Benchmarks on fertility

Countries side by side on public measures for this topic.

All benchmarks

EU medicine approvals on related topics

All topics

Acuitas market sizes and forecasts are only in our full reports. How we use public data.